21 Aug 2018 07:00
Tiziana Life Sciences plc
(Incorporated in England and Wales with company number 09665181)
PDMR dealings
Tiziana Life Sciences plc (LSE: TILS) (the "Company") announces that on 20 August 2018, Dr Shailubhai Kunwar, Chief Executive Officer and Tiziano Lazzaretti, Chief Financial Officer bought shares in the Company as follows :
The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:
1. | Details of PDMR / person closely associated | |||
a) | Name | Dr Shailubhai Kunwar | ||
2. | Reason for the notification: On market acquisition | |||
a) | Position / status | Chief Executive Officer | ||
b) | Initial notification /amendment | Initial notification | ||
3. | Details of the issuer | |||
a) | Name | Tiziana Life Sciences plc | ||
b) | LEI | 213800CED47HI8PIOB36 | ||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
a) | Description of the financial instrument | Ordinary Shares of 3p each | ||
b) | Identification code of the Financial Instrument | ISIN for Tiziana Life Sciences plc: GB00BKWNZY55 | ||
c) | Nature of the transaction | Acquisition of shares | ||
d) | Price(s) and volume(s) | Price: £1.01; Volume: 5,000 | ||
e) | Aggregated information - Aggregated volume - Price |
5,000 £5,050
| ||
f) | Date of the transaction | 20 August 2018 | ||
g) | Place of the transaction | XLON | ||
1. | Details of PDMR / person closely associated | |||
a) | Name | Tiziano Lazzaretti | ||
2. | Reason for the notification: On market acquisition | |||
a) | Position / status | Chief Financial Officer | ||
b) | Initial notification /amendment | Initial notification | ||
3. | Details of the issuer | |||
a) | Name | Tiziana Life Sciences plc | ||
b) | LEI | 213800CED47HI8PIOB36 | ||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
a) | Description of the financial instrument | Ordinary Shares of 3p each | ||
b) | Identification code of the Financial Instrument | ISIN for Tiziana Life Sciences plc: GB00BKWNZY55 | ||
c) | Nature of the transaction | Acquisition of shares | ||
d) | Price(s) and volume(s) | Price: £0.80; Volume: 2,000 | ||
e) | Aggregated information - Aggregated volume - Price |
2,000 £1,625
| ||
f) | Date of the transaction | 20 August 2018 | ||
g) | Place of the transaction | XLON | ||
Neither Dr Shailubhai nor Mr Lazzaretti were holders of shares in the Company prior to the acquisitions set out above.
For more information go to http://www.tizianalifesciences.com
Contacts:
Tiziana Life Sciences plc Gabriele Cerrone, Chairman and founder
|
+44 (0)20 7493 2853 |
Cairn Financial Advisers LLP (Nominated adviser) Liam Murray / Jo Turner | +44 (0)20 7213 0883 |
Stockdale Securities (Broker) Antonio Bossi / Andy Crossley
| +44 (0)20 7601 6100 |